secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIGAND PHARMACEUTICALS INC (LGND)
CIK:        0000886163
Form:       8-K
Filed at:   2022-12-14T23:59:59+00:00
Accession:  0000886163-22-000140
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ligand increases base salary and target bonus for President/COO and CFO
-----------------------------------------------------------------------

- Matthew Korenberg (President & COO) base salary set at $540,000 with 50% target bonus.
- Octavio Espinoza (CFO) base salary set at $400,000 with 40% target bonus.
- Changes effective December 5, 2022, tied to recent promotions to these roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886163/000088616322000140/0000886163-22-000140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886163/000088616322000140/lgnd-20221213.htm
  HTML page:      https://secwatch.observer/filing/0000886163-22-000140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer